A comparison of the impact of anti-IL5/5R therapies in allergic versus non-allergic patients with severe eosinophilic asthma in a real-life setting.

Tatiana Navarro-CascalesMonica Colque-BayonaInés Fernandez-ConchaDaniel Laorden Santiago QuirceJavier Domínguez-Ortega

Published in: The Journal of asthma : official journal of the Association for the Care of Asthma (2024)

Anti-IL5/IL5R reduced the need for OCS and improved asthma control, regardless of allergic status. Fungal allergy led to lower ACT scores and higher exacerbations than other allergens; both groups improved with anti-IL5/ILR.

Keyphrases

allergic rhinitis
chronic obstructive pulmonary disease
lung function
atopic dermatitis
early onset
air pollution